Global Veterinary Drugs Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Anti-infectives, Anti-inflammatory, Parasiticides, Others

By Animal Type;

Companion and Livestock.

By Route of Administration;

Oral, Parenteral, and Topical.

By Distribution Channel;

Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn666377666 Published Date: March, 2025 Updated Date: April, 2025

Introduction

Global Veterinary Drugs Market (USD Million), 2021 - 2031

In the year 2024, the Global Veterinary Drugs Market was valued at USD 27,222.37 million. The size of this market is expected to increase to USD 39,077.30 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.3%.

The global veterinary drugs market stands as a cornerstone of animal healthcare, catering to the diverse medical needs of companion animals, livestock, and even exotic species. With a vast array of pharmaceuticals, vaccines, and medicinal products, this market plays a pivotal role in ensuring the well-being and productivity of animals worldwide.

The veterinary drugs market has witnessed significant growth propelled by several factors. Increased awareness among pet owners regarding preventive care, coupled with rising incidences of zoonotic diseases, has spurred demand for veterinary medications. Additionally, advancements in veterinary science, including innovative drug formulations and treatment modalities, have expanded the market's scope, driving both investment and research in this sector.

The evolving regulatory landscape and growing emphasis on animal welfare have reshaped the dynamics of the veterinary drugs market. Stricter regulations governing the approval and usage of veterinary pharmaceuticals, along with heightened scrutiny on antibiotic usage in livestock, have prompted industry players to prioritize research into safer and more effective treatment options. As such, the global veterinary drugs market continues to evolve, presenting both challenges and opportunities for stakeholders across the healthcare spectrum.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Animal Type
    3. Market Snapshot, By Route of Administration
    4. Market Snapshot, By Distribution Channel
    5. Market Snapshot, By Region
  4. Global Veterinary Drugs Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Pet Ownership
        2. Advancements in Veterinary Medicine
        3. Rising Livestock Demand
      2. Restraints
        1. Stringent Regulatory Framework
        2. High Costs of Veterinary Drugs
        3. Lack of Awareness in Developing Regions
      3. Opportunities
        1. Emerging Markets Expansion
        2. Technological Innovations
        3. Growing Focus on Animal Health
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Compititive Rivalry
  5. Market Segmentation
    1. Global Veterinary Drugs Market, By Product, 2021 - 2031 (USD Million)
      1. Anti-infectives
      2. Anti-inflammatory
      3. Parasiticides
      4. Others
    2. Global Veterinary Drugs Market, By Animal Type, 2021 - 2031 (USD Million)
      1. Companion
      2. Livestock
    3. Global Veterinary Drugs Market, By Route of Administration, 2021 - 2031 (USD Million)
      1. Oral
      2. Parenteral
      3. Topical
    4. Global Veterinary Drugs Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Bayer AG
      2. Boehringer Ingelheim GmbH
      3. Ceva Sant Animale
      4. Dechra Pharmaceuticals PLC
      5. Eli Lilly and Company (Elanco Animal Health)
      6. Merck Animal Health
      7. Virbac
      8. Vetoquinol S.A.
      9. Zoetis Inc.
  7. Analyst Views
  8. Future Outlook of the Market